Matinas Biopharma Hl (MTNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,447 | -17,373 | -14,083 | -15,487 | -7,599 |
| Depreciation Amortization | 1,014 | 781 | 218 | 101 | 53 |
| Income taxes - deferred | N/A | N/A | -507 | -357 | N/A |
| Accounts payable and accrued liabilities | -329 | 384 | -287 | 107 | -22 |
| Other Working Capital | -509 | -492 | 160 | 528 | -94 |
| Other Operating Activity | 4,903 | 2,608 | 4,178 | 3,648 | 1,543 |
| Operating Cash Flow | $-17,368 | $-14,092 | $-10,321 | $-11,460 | $-6,119 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -40,661 | -5,606 | N/A | N/A | N/A |
| PPE Investments | -6 | -406 | -536 | -942 | N/A |
| Investing Cash Flow | $-40,667 | $-6,011 | $-536 | $-942 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -55 | -282 | -429 | -348 | -160 |
| Common Stock Issued | 48,102 | 30,134 | N/A | 14,828 | 315 |
| Other Financing Activity | 0 | 0 | 16,296 | 1,122 | 6,842 |
| Financing Cash Flow | $48,047 | $29,852 | $15,867 | $15,603 | $6,997 |
| Beginning Cash Position | 22,756 | 13,008 | 7,998 | 4,797 | 3,227 |
| End Cash Position | 12,769 | 22,756 | 13,008 | 7,998 | 4,106 |
| Net Cash Flow | $-9,988 | $9,749 | $5,010 | $3,201 | $879 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,368 | -14,092 | -10,321 | -11,460 | -6,119 |
| Capital Expenditure | -6 | -406 | -536 | -942 | N/A |
| Free Cash Flow | -17,374 | -14,498 | -10,857 | -12,402 | -6,119 |